Measles would likely be the first eradicated disease to return, because it is so highly contagious, but other diseases like ...

With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

Flu activity continues to ebb nationwide, with rates of influenza-like illness (ILI) dropping further last week, but ...

The US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) has reported 6 more H5N1 avian flu ...

Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...

A new study to boost the number of expectant mothers having the Respiratory Syncytial Virus (RSV) immunisation and ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

Pfizer's PFE non-COVID operational revenues improved in 2024, driven by its key in-line products like Vyndaqel, Padcev and ...

A single-dose of the respiratory syncytial virus (RSV) vaccine in older adults showed waning efficacy across three seasons of ...

The COVID vaccine brought a renewed public debate around vaccines. A new film airing on PBS explores the politicization of ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...